TK
Takara Bio Inc.
TKBIF · OTC
$7.30 +0.00% (+$0.00)
Market Cap $879.0M
P/E Ratio -
Div. Yield 1.58%
ROE 9.37%
Valuation
34 /100
Fair EV/EBITDA 206.30x
P/S 3.32x
P/B 1.35x
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 50.43%
Net margin 24.20%
FCF margin 22.85%
Quality
4 /100
Poor ROIC 4.08%
ROE 9.37%
Asset turnover 0.31x
Debt
80 /100
Low Debt/Equity 0.11x
Current ratio 5.76x
Net debt/EBITDA -15.01x
Stability
58 /100
Moderate Beta 0.43x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o TKBIF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tsuyoshi Miyamura
Employees
1,838
Headquarters
Kusatsu